Blaming Vitamin C Price Hike On SARS Absurd, Jury Hears

Law360, New York (March 11, 2013, 7:10 PM EDT) -- A report commissioned by Chinese vitamin C manufacturers attributing sharp price increases to fears over SARS and avian flu outbreak — as opposed to industry collusion — is "nonsensical" and riddled with mathematical errors, a Stanford University economics professor testified Monday in a multidistrict litigation before a New York federal jury.

B. Douglas Bernheim criticized the report, which determines Chinese manufacturers should at most be on the hook for $2.2 million in damages for alleged price-fixing, substantially less than the $54.1 million U.S. companies are seeking...
To view the full article, register now.